Merck signs agreement to buy Pandion Therapeutics for $1.85bn
Merck has agreed to acquire biotechnology company Pandion Therapeutics for approximately $1.85bn to expand its portfolio of autoimmune disease-targeting candidates.…
Most Read
FDA finds J&J’s single-dose Covid-19 vaccine safe and effective in trials
Sinovac’s Covid-19 vaccine gets approval in Thailand for emergency use
Novavax concludes subject enrolment in Covid-19 vaccine trial
Russia grants approval to third Covid-19 vaccine for domestic use
Pfizer and BioNTech begin Covid-19 vaccine trial in pregnant women
Janssen-Cilag seeks EMA authorisation for Covid-19 vaccine candidate
WHO grants Emergency Use Listing to AstraZeneca’s Covid-19 vaccine
